Teva Sues To Invalidate Nexium Patents
Israeli generics maker Teva Pharmaceutical Industries Inc. has sued AstraZeneca Plc for a declaratory judgment that several of AstraZeneca's patents related to its popular anti-ulcer drug Nexium are invalid....To view the full article, register now.
Already a subscriber? Click here to view full article